Search results
Results from the WOW.Com Content Network
In 2007 the Human Genetics Unit formed a partnership with two neighbouring research centres on the Western General Hospital campus, the Centre for Genomic and Experimental Medicine (University of Edinburgh) and the Edinburgh Cancer Research Centre (Cancer Research UK), to create the Institute of Genetics and Molecular Medicine.
Sir Bruce Anthony John Ponder FMedSci FAACR FRS FRCP (born 25 April 1944) is an English geneticist and cancer researcher. He is Emeritus Professor of Oncology at the University of Cambridge and former director of the Cancer Research UK Cambridge Institute and of the Cancer Research UK Cambridge Cancer Centre.
She specialises in research into the genetic mechanisms that cause cancer, particularly among groups with a predisposition to pediatric cancers or breast cancer. [8] Through her research, Professor Rahman has provided improved screening and treatment options for NHS patients, and also provides advice on rare cancer genetics to clinicians ...
Walter Nance (born 1933), US internist and geneticist, research on twins and genetics of deafness; Daniel Nathans (1928–1999), US microbiologist, Nobel Prize for restriction endonucleases; James V. Neel (1915–2000), US human geneticist who contributed to the development of research on human genetics, and founded the first genetics clinic in ...
The Edinburgh Cancer Research Centre was established in The University of Edinburgh (UoE) in close partnership with Cancer Research UK and the NHS Lothian, and has strong links to other Institutes and Colleges conducting cancer research in Edinburgh, in particular the Institute of Genetics & Molecular Medicine. The ECRC follows a partnership ...
Paul Workman. Workman was born on 30 March 1952 in Workington, Cumbria, England. [2] He was educated at Workington County Grammar School, Cumbria, and completed his BSc degree in Biochemistry at the University of Leicester and his PhD degree in Cancer Pharmacology at the University of Leeds.
The identification of GEN1 was the culmination of 18 years of research, and opened up the field to allow a genetic analysis of the pathways by which recombination intermediates are processed. Present understanding indicates that there are three distinct pathways of Holliday junction processing in human cells involving BLM-topoIIIα-RMI1-RMI2 ...
In follow-up research at the ICR in 1964, Professors Peter Brookes and Philip Lawley proved that chemical carcinogens act by damaging DNA, leading to mutations and the formation of tumours, proving that cancer is a genetic disease based on mutational events. [7] In 1954 the institute was officially renamed The Institute of Cancer Research (ICR).